A fresh analysis questioned why a major wave of investment in kidney care hasn’t translated into lower hospital costs. The piece argues the issue may be less about the funding itself and more about the intervention targets—suggesting that cost outcomes depend on aligning spending with the right clinical levers and care settings. For hospital systems, the message is operational: even well-funded kidney programs may fail to move total cost of care if they don’t reduce the cost drivers that dominate utilization. The report frames the debate around intervention design rather than simply budget magnitude, which could influence how payers and providers structure next-generation renal models.